Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

John C. Markowitz, MD

Articles by John C. Markowitz, MD

"Evidence indicates that psychotherapy may yield greater durability of treatment gains than pharmacotherapy."

Psychotherapy for Treatment-Resistant Depression Is Overlooked, Underused

ByDonna M. Sudak, MD,John C. Markowitz, MD,Jesse H. Wright, MD, PhD

November 17th 2023

"Evidence indicates that psychotherapy may yield greater durability of treatment gains than pharmacotherapy."

Latest Updated Articles

Psychotherapy for Treatment-Resistant Depression Is Overlooked, Underused
Published: November 17th 2023 | Updated:

Trending on Psychiatric Times

The Trial of ChatGPT: What Psychiatrists Need to Know About AI, Suicide, and the Law

Preliminary Report on Dangers of AI Chatbots

Closing the Gap in Schizophrenia Care: Insights From the INTEGRATE Guidelines

6 Helpful Pearls From the International Guidelines for Algorithmic Treatment of Schizophrenia

Fostering Resiliency in Mental Health Professionals: A Strengths-Based, Trauma-Informed Framework

© 2025 MJH Life Sciences^®

All rights reserved.